| Entry |
|
|---|
| Name |
Epoetin alfa (genetical recombination) (JP16);
Epoetin alfa (USAN/INN);
Epogen (TN)
|
|---|
| Product |
|
|---|
| Formula |
C809H1301N229O240S5
|
|---|
| Exact mass |
18224.5242
|
|---|
| Mol weight |
18235.7015
|
|---|
| Sequence |
APPRLICDSR VLERYLLEAK EAENITTGCA EHCSLNENIT VPDTKVNFYA WKRMEVGQQA
VEVWQGLALL SEAVLRGQAL LVNSSQPWEP LQLHVDKAVS GLRSLTTLLR ALGAQKEAIS
PPDAASAAPL RTITADTFRK LFRVYSNFLR GKLKLYTGEA CRTGD
(Disulfide bridge: 7-161; 29-33) |
|---|
| Type |
Peptide |
|---|
| Activity |
Anti-anemic;
Hematinic
|
|---|
| Remark |
Therapeutic category: ATC code: |
|---|
| Target |
erythropoietin receptor agonist [HSA: 2057] [KO: K05079] |
|---|
| Pathway |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D03231 Epoetin alfa (genetical recombination) (JP16); Epoetin alfa (USAN/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B03 ANTIANEMIC PREPARATIONS
B03X OTHER ANTIANEMIC PREPARATIONS
B03XA Other antianemic preparations
B03XA01 Erythropoietin
D03231 Epoetin alfa (genetical recombination) (JAN); Epoetin alfa (USAN/INN)
USP drug classification [BR:br08302]
Blood Products / Modifiers / Volume Expanders
Blood Formation Modifiers
Erythropoietins
Epoetin alfa
D03231 Epoetin alfa (genetical recombination) (JAN); Epoetin alfa (USAN/INN)
Target-based classification of drugs [BR:br08310]
Cytokine receptors
Class I cytokine receptors (hematopoietin family receptors)
erythropoietin receptor [HSA:2057] [KO:K05079]
Erythropoietin [ATC:B03XA01]
D03231 Epoetin alfa (genetical recombination) (JAN); Epoetin alfa (USAN/INN)
Antineoplastics [BR:br08308]
Biologic response modifiers
Myeloid- and erythroid-stimulating factors
Erythropoietin [ATC:B03XA01]
D03231 Epoetin alfa (genetical recombination) (JAN); Epoetin alfa (USAN/INN)
 |
|---|
| Other DBs |
CAS: 113427-24-0 PubChem: DrugBank: |
|---|
